The independent cooperative i+Med from Alava has presented a three-year investment project worth 20 million euros, which includes the launch of the Biomedical Institute of Intelligent Nanohydrogels (IIBNI). It will be the first of its kind in the world and will position i+Med in the medium and long term as a world leader in personalised medicine through artificial intelligence systems integrated directly into nanohydrogels.

The new Institute that i+Med is planning will be located in the Alava Technology Park. Its start-up will create 60 new highly qualified jobs. Work will begin this year and is expected to be completed by the end of 2024.

Translated with (free version)